Target Trial Emulation Applications in Hypertension Research: A Scoping Review
Bibliographic record
Abstract
Abstract Objectives Target Trial Emulation (TTE) has emerged as a rigorous framework for causal inference using observational data, but its application in hypertension research remains underexplored. This scoping review aims to map current TTE applications, identify methodological strengths and weaknesses, and propose future directions for its use in hypertension research. Study Design and Setting We performed a scoping review following the Joanna Briggs Institute (JBI) guidance and the PRISMA extension for Scoping Reviews (PRISMA-ScR) checklist. We searched multiple databases, and three independent reviewers conducted screening and extraction using Covidence review management software. 14 out of 1,352 articles met the inclusion criteria. Results Most studies used data from electronic health records, claims databases, and registries. All of the interventions were pharmacological except for one. Common confounding adjustment methods included inverse probability weighting (50%) and the g-formula (21.5%), complemented by regression-based models. However, time-varying confounders were inconsistently addressed, and loss to follow-up was often managed through simple censoring rather than statistical methods. Residual confounding remained a concern—although several studies acknowledged unobserved confounders, only five (36%) employed negative controls or e-values to assess their impact. While subgroup analyses were common, explicit heterogeneous treatment effect (HTE) estimation was limited. Advanced causal machine learning techniques for bias mitigation or HTE detection were not reported. Conclusion TTE shows strong potential to complement randomized controlled trials in hypertension research by providing more generalizable insights. While still in its early stages, current studies highlight its ability to address key challenges such as HTE, long-term outcomes, and dynamic treatment strategies.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.270 | 0.629 |
| Meta-epidemiology (narrow) | 0.003 | 0.003 |
| Meta-epidemiology (broad) | 0.012 | 0.019 |
| Bibliometrics | 0.027 | 0.028 |
| Science and technology studies | 0.002 | 0.004 |
| Scholarly communication | 0.012 | 0.013 |
| Open science | 0.006 | 0.009 |
| Research integrity | 0.008 | 0.006 |
| Insufficient payload (model declined to judge) | 0.010 | 0.002 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; the direct Gemma label and the distilled Codex classifier agree on what is shown here.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".